Tricuspid-Valve Intervention in Heart Failure.

Transcatheter tricuspid-valve repair significantly reduces death and hospitalization risks in patients with severe tricuspid regurgitation, with a win ratio of 2.42 at 1 year.

• Why it matters: Severe tricuspid regurgitation is linked to poor outcomes, but the impact of repair procedures on survival and hospitalizations has been uncertain, highlighting a critical gap in treatment evidence.
• What they did: The study randomized 360 patients with symptomatic severe tricuspid regurgitation to receive either tricuspid-valve repair plus medical therapy or medical therapy alone, assessing outcomes over three years.
• The result: Tricuspid-valve repair improved survival and reduced hospitalizations, with a 52.4% freedom from death or heart failure hospitalization at three years, enabling better long-term management of high-risk patients.